Co-Founder, Chief Science Officer at Kurve Therapeutics, Inc. - Lynnwood, Washington, United States
Kurve Therapeutics' goal is to advance next-generation treatments for neurodegenerative diseases. Our patented Controlled Particle Dispersion® (CPD) intranasal drug delivery technology has been shown to bypass the blood-brain barrier.